Prentice Wealth Management LLC Neurocrine Biosciences Inc Transaction History

Prentice Wealth Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$75.79 - $100.07 $6,517 - $8,606	-86 Reduced 51.5%	81 $8,000
Q3 2021 Nov 10, 2021	SELL	$86.18 - $99.03 $4,395 - $5,050	-51 Reduced 23.39%	167 $16,000
Q2 2021 Aug 11, 2021	SELL	$89.43 - $102.27 $715 - $818	-8 Reduced 3.54%	218 $21,000
Q1 2021 Jun 17, 2021	SELL	$87.57 - $119.4 $1.9 Million - $2.6 Million	-21,753 Reduced 98.97%	226 $22,000
Q1 2021 Jun 08, 2021	BUY	$87.57 - $119.4 $1.92 Million - $2.62 Million	21,979 New	21,979 $22,000

625

94.2M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Prentice Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Prentice Wealth Management LLC with notifications on news.